Announcements Trials
Browse Landscape Eligibility

Clinical Trials

2 trials
RecentStart dateEnrollment
TEMPO × Clear all

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Motor Activity 2Anxiety Disorders 2Neoplasms 1

Interventions

Cisplatin 3176Cyclophosphamide 3170Carboplatin 2955Radiotherapy 2772Paclitaxel 2705Gemcitabine 2549pembrolizumab 2368Bevacizumab 2191Docetaxel 2190Fluorouracil 1837Capecitabine 1815Oxaliplatin 1723Dexamethasone 1589Nivolumab 1575Doxorubicin 1500Rituximab 1480Magnetic Resonance Spectroscopy 1365Etoposide 1341Irinotecan 1240Leucovorin 1215Drug Therapy 1189Cytarabine 1125Pemetrexed 1067fludarabine 1035Specimen Handling 985Vincristine 962Cetuximab 938Prednisone 938Trastuzumab 936Lenalidomide 932

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT06363266 2025-05-06

A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers

St. Mary's Research Center, Canada

Phase NA Recruiting
376 enrolled
Genitourinary

Anxiety Disorders, Motor Activity, Prostatic Neoplasms

NCT04304196 2021-09-21

TEMPO

St. Mary's Research Center, Canada

Phase NA Completed
82 enrolled
Genitourinary

Anxiety Disorders, Motor Activity, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡